TLDR A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.
The document reported a case of a 10-year-old girl with chronic hepatitis B who developed both vitiligo and psoriasis after being treated with interferon alfa-2a. These skin conditions did not improve even after the interferon treatment was stopped. This was notable because the simultaneous occurrence of vitiligo and psoriasis as a side effect of interferon alfa-2a had not been previously documented. The study highlighted the potent immunomodulatory effects of interferon alfa-2a, which can trigger autoimmune diseases in susceptible individuals.
105 citations,
September 1995 in “Journal of The American Academy of Dermatology” Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.
41 citations,
August 2007 in “European Journal of Gastroenterology & Hepatology” A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.
March 2014 in “Journal of The American Academy of Dermatology” The document lists various dermatology topics, treatments, and diagnostic methods.
3 citations,
March 2014 in “Annals of Hepatology” A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.
64 citations,
January 2009 in “Canadian Journal of Gastroenterology” Interferon and ribavirin can cause serious skin reactions and other health issues.
34 citations,
April 2008 in “Journal of the European Academy of Dermatology and Venereology” Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.
